LFVN LifeVantage Corporation

6.000USD-0.66%Mkt Cap: 75.54M $P/E: 15.00

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair c…

Key Statistics

Company
Market Cap75.54M USD
Enterprise Value70.61M USD
Revenue (TTM)182.59M USD
Gross Profit141.61M USD
Net Income (TTM)5.07M USD
Revenue/Share14.57 USD
Last Price6.000 USD
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees209
CountryUS
SectorConsumer Defensive
IndustryPackaged Foods
ISIN—
Valuation
P/E (Trailing)15.00
P/E (Forward)15.62
PEG0.36
EV/EBITDA7.45
EV/Revenue0.39
P/S0.42
P/B2.25
EPS (TTM)0.40
EPS (Forward)0.39
52W Range
3.90027% of range11.71
52W High11.71 USD
52W Low3.900 USD
Profitability
Gross Margin77.56%
Oper. Margin3.93%
EBITDA Margin5.19%
Profit Margin2.78%
ROE15.10%
ROA8.17%
Growth
Revenue Growth-23.10%
Earnings Growth-32.80%
Cash Flow & Leverage
Operating CF10.24M USD
CapEx (TTM)3.57M USD
FCF Margin3.29%
FCF Yield7.95%
Net Debt-5.05M USD
Net Debt/EBITDA-0.53
Balance Sheet
Debt/Equity0.29
Current Ratio1.89
Quick Ratio0.95
Book Value/Sh2.68 USD
Cash/Share1.19 USD
Dividends
Fwd Div Rate0.20 USD
Trail. Div Rate0.18 USD
Div. Yield3.31%
5Y Avg Yield1.64%
Payout Ratio46.25%
Ex-Div DateSep 1, 2026
Pay DateSep 15, 2026
Splits
Last Split1:7
Split DateOct 19, 2015
Analyst Consensus
Rating—
Target (Mean)7.500 USD
Upside (mean)+25.0%
Target Range6.000 USD – 9.000 USD
6.000+25.0% to mean9.000
# Analysts2
Ownership
Shares Out.12.59M
Float9.09M
Insiders11.99%
Institutions53.67%
Short Interest
Short Ratio21.6d
Short % Float11.43%
Short % Out.9.04%
Shares Short1.14M
Short (prev mo.)1.21M
Technical
SMA 506.392 (-6.1%)
SMA 2005.914 (+1.4%)
Beta0.71
S&P 52W Chg16.45%
Avg Vol (30d)43.46K
Avg Vol (10d)32.42K
Technical Indicators
RSI (14)38.9
MACD-0.0914
MACD Signal-0.0724
MACD Hist.-0.0190
BB Upper6.481 USD
BB Middle6.228 USD
BB Lower5.974 USD
BB Width8.15%
ATR (14)0.2619 USD
Vol Ratio (20d)0.61x